BE439329A - - Google Patents
Info
- Publication number
- BE439329A BE439329A BE439329DA BE439329A BE 439329 A BE439329 A BE 439329A BE 439329D A BE439329D A BE 439329DA BE 439329 A BE439329 A BE 439329A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- vitamin
- substances
- oil
- vitamins
- Prior art date
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 24
- 229940088594 vitamin Drugs 0.000 claims description 24
- 239000011782 vitamin Substances 0.000 claims description 24
- 229930003231 vitamin Natural products 0.000 claims description 23
- 235000013343 vitamin Nutrition 0.000 claims description 23
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 18
- 239000011709 vitamin E Substances 0.000 claims description 17
- 235000019165 vitamin E Nutrition 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 12
- 229930003427 Vitamin E Natural products 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 9
- 229940046009 vitamin E Drugs 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 19
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 11
- 238000007792 addition Methods 0.000 description 11
- 239000002023 wood Substances 0.000 description 9
- 125000005456 glyceride group Chemical group 0.000 description 7
- 229930003799 tocopherol Natural products 0.000 description 7
- 239000011732 tocopherol Substances 0.000 description 7
- 229960001295 tocopherol Drugs 0.000 description 7
- 235000010384 tocopherol Nutrition 0.000 description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000000087 stabilizing effect Effects 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 238000006317 isomerization reaction Methods 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229940066595 beta tocopherol Drugs 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000013310 margarine Nutrition 0.000 description 2
- 239000003264 margarine Substances 0.000 description 2
- JBYXPOFIGCOSSB-UHFFFAOYSA-N octadeca-9,11-dienoic acid Chemical compound CCCCCCC=CC=CCCCCCCCC(O)=O JBYXPOFIGCOSSB-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011590 β-tocopherol Substances 0.000 description 2
- 235000007680 β-tocopherol Nutrition 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE439329A true BE439329A (enExample) |
Family
ID=97335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE439329D BE439329A (enExample) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE439329A (enExample) |
-
0
- BE BE439329D patent/BE439329A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2466321C (fr) | Gel comprenant au moins un retinoide et du peroxyde de benzoyle | |
| JP5827784B2 (ja) | ビタミンｋ２を含む医薬及び栄養補助製品 | |
| FR2553662A1 (fr) | Composition d'acides gras combines, pour reduire les taux de triglycerides et de cholesterol du sang | |
| FR2537980A1 (fr) | Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation | |
| FR2674525A1 (fr) | Vitamine e polyethoxylee et son procede de preparation. | |
| EP0796238B1 (fr) | Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises en therapeutique et en cosmetologie | |
| EP0131176A1 (fr) | Protection antioxygène des produits alimentaires et cosmétiques | |
| WO2000032184A1 (en) | Skin preparations for external use | |
| WO2018162617A1 (fr) | AceFaPC POUR LE TRAITEMENT DES MALADIES ACÉTYLCHOLINE DÉPENDANTES | |
| EP2167016B1 (fr) | Hydrogel de carboxyalkylamide de chitosan, sa preparation et son utilisation cosmetique et dermatologique | |
| WO1996002488A9 (fr) | Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises en therapeutique et en cosmetologie | |
| WO2012059702A1 (fr) | Procede de production d'une composition emulsifiante a base de lecithine hydrogenee. | |
| FR2460672A1 (fr) | Preparation de poudre d'acetylsalicylate pour injection | |
| CA2325887A1 (fr) | Procede d'obtention d'une huile enrichie en acides gras hydroxyoctadecadienoiques (hode) ou de ses esters, a partir d'un melange huileux contenant de l'acide linoleique, ou ses esters | |
| WO2007107679A2 (fr) | Association de substance oleagineuse avec un melange d'au moins deux cyclodextrines | |
| MC1265A1 (fr) | Preparation d'un medicament a base de prostaglandines | |
| RU2630606C2 (ru) | Устойчивые составы антитромбоцитарных средств, омега-3 жирных кислот и амилозы в мягких желатиновых капсулах | |
| BE898430A (fr) | Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation. | |
| FR2839887A1 (fr) | Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations | |
| FR2635463A1 (fr) | Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glyceride gelifie par au moins un polymere cellulosique | |
| JP2000327570A (ja) | 皮膚外用剤 | |
| FR2487675A1 (fr) | Nouvelles compositions pharmaceutiques injectables a base d'une phenothiazine | |
| CH652024A5 (fr) | Composition contre la transpiration. | |
| FR2638742A1 (fr) | Complexe forme a partir de sels de cations bivalents de l'acide acetylsalicylique et de l'uree - leur procede de fabrication, leurs applications therapeutiques basees sur les activites pharmacologiques | |
| FR2513517A1 (fr) | Nouvelles compositions a usage pharmaceutique, dietetique et cosmetologique rendues gastro-resistantes, riches en acides gras essentiels polyinsatures et leur procede de preparation |